Researchers found that treating patients who have resectable malignant pleural mesothelioma, meaning that their tumor can be removed with surgery, with immunotherapy ahead of surgery resulted in favorable clinical outcomes.
Click here for original story, Preoperative immunotherapy for mesothelioma shows favorable outcomes
Source: ScienceDaily